Company / Shareholders' Equity
ORAGENICS INC Shareholders' Equity History
FY2013-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$211.9K
FY2024
5-year range
-$211.9K / $26.5M
FY2020-FY2024
Trend
-101.6%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
ORAGENICS INC reports negative total equity of -$211,885 in FY2024. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$211,885 in FY2024.
Declined from $26M to -$211,885 over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, shareholders' equity decreased 101.6% year-over-year.
- Peak shareholders' equity was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -147.03 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$211.9K | -101.6% |
| FY2023 | $13.0M | -50.9% |
| FY2022 | $26.5M | +0.0% |
| FY2021 | $26.5M | +26.8% |
| FY2018 | $20.9M | +604.1% |
| FY2017 | $3.0M | -37.3% |
| FY2016 | $4.7M | -54.2% |
| FY2015 | $10.3M | +0.0% |
| FY2014 | $10.3M | +12.0% |
| FY2013 | $9.2M | +0.0% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026